BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17276544)

  • 1. Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone.
    Damian DL; Thompson JF
    J Am Acad Dermatol; 2007 May; 56(5):869-71. PubMed ID: 17276544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.
    Damian DL; Shannon KF; Saw RP; Thompson JF
    Australas J Dermatol; 2009 Nov; 50(4):266-71. PubMed ID: 19916970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.
    Damian DL; Saw RP; Thompson JF
    J Surg Oncol; 2014 Mar; 109(4):308-13. PubMed ID: 24522938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.
    Trefzer U; Sterry W
    Dermatology; 2005; 211(4):370-1. PubMed ID: 16286751
    [No Abstract]   [Full Text] [Related]  

  • 5. Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.
    Gibbons IL; Sonagli M; Bertolli E; Macedo MP; Pinto CAL; Duprat Neto JP
    An Bras Dermatol; 2018 Mar; 93(2):299-301. PubMed ID: 29723355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.
    Gulati N; Carvajal RD; Postow MA; Wolchok JD; Krueger JG
    Exp Dermatol; 2016 Jul; 25(7):553-4. PubMed ID: 27061281
    [No Abstract]   [Full Text] [Related]  

  • 7. Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine.
    Harland CC; Saihan EM
    Lancet; 1989 Aug; 2(8660):445. PubMed ID: 2569622
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete remission of extensive cutaneous metastatic melanoma on the scalp under topical mono-immunotherapy with diphenylcyclopropenone.
    Hinz T; Ehler LK; Bieber T; Schmid-Wendtner MH
    Eur J Dermatol; 2013; 23(4):532-3. PubMed ID: 24002471
    [No Abstract]   [Full Text] [Related]  

  • 9. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience.
    Moncrieff M; Fadhil M; Garioch J
    Br J Dermatol; 2016 May; 174(5):1141-2. PubMed ID: 26598951
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical diphencyprone immunotherapy for a large primary melanoma on an elderly leg.
    Damian DL; Thompson JF
    Am J Clin Dermatol; 2011 Dec; 12(6):403-4. PubMed ID: 21967115
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital malignant melanoma and cutaneous metastases treated with diphencyprone.
    Fawcett JM; Newell EL; Kennedy CT
    Clin Exp Dermatol; 2016 Mar; 41(2):212-3. PubMed ID: 26053880
    [No Abstract]   [Full Text] [Related]  

  • 13. Intralesional therapy of metastatic spreading melanoma with beta-interferon.
    Rapprich H; Hagedorn M
    J Dtsch Dermatol Ges; 2006 Sep; 4(9):743-6. PubMed ID: 16928243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience in the treatment of cutaneous in-transit melanoma metastases and satellitosis with intralesional interleukin-2].
    Dehesa LA; Vilar-Alejo J; Valerón-Almazán P; Carretero G
    Actas Dermosifiliogr; 2009 Sep; 100(7):571-85. PubMed ID: 19715642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
    Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
    Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata.
    Firooz A; Bouzari N; Mojtahed F; Pazoki-Toroudi H; Nassiri-Kashani M; Davoudi M; Dowlati Y
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):393-4. PubMed ID: 15857483
    [No Abstract]   [Full Text] [Related]  

  • 19. Response rates of cutaneous melanoma metastases to diphencyprone: A meta-analysis.
    Lôbo MM; Calsavara VF; Ricci BV; Lopes Pinto CA; Bertolli E; Duprat Neto JP
    J Am Acad Dermatol; 2020 Dec; 83(6):1812-1813. PubMed ID: 32289400
    [No Abstract]   [Full Text] [Related]  

  • 20. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.